Business Standard

Moderna discards 400,000 Covid-19 vaccines, says will meet production goal

The loss is somewhat of a drop in the bucket for Moderna's overarching objective of producing 500 million to 1 billion doses in 2021

moderna
Premium

Moderna has been co-developing its Covid-19 candidate with the National Institute of Allergy and Infectious Diseases, a unit of the National Institutes of Health

Riley Griffin | Bloomberg
Moderna Inc. had to discard 400,000 doses of its experimental Covid-19 shot after a filtration issue compromised the product during the final stages of manufacturing, a U.S. official said Thursday.
 
Moncef Slaoui, Operation Warp Speed’s chief scientific adviser, disclosed Moderna’s manufacturing hiccup in an interview with Bloomberg News. The 400,000 doses, which weren’t yet placed in vials, were part of a broader 1.4 million batch of its vaccine, Slaoui said.

Moderna, however, remains on track to meet its production estimates of 20 million doses this month, and 85 to 100 million doses for the U.S. in the first quarter of 2021,

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Dec 18 2020 | 4:02 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com